Categories : Anti-Infectives
Product Packaging : 1 vial
Product Composition : 1125 mg
Send MessageGenliva Wellness LLP formulates Cefoperazone & Tazobactam Injection for aggressive bacterial infections requiring higher antibacterial strength in hospital and intensive care environments. The injection is widely administered in ventilator-associated pneumonia, septicemia, abdominal infections, complicated urinary tract infections, and post-operative bacterial complications.
Cefoperazone attacks susceptible bacterial pathogens by disrupting bacterial cell wall formation, while Tazobactam blocks beta-lactamase enzymes responsible for bacterial resistance. The combination is frequently selected in critical infection cases where resistant bacterial organisms are suspected.
Genliva Wellness LLP manufactures sterile injectable antibiotic formulations under controlled production systems for hospital procurement programs, institutional pharmaceutical supply, and advanced critical care treatment requirements.
Cefoperazone & Tazobactam Injection combines cephalosporin and beta-lactamase inhibitor activity for hospital antibacterial therapy.
This injectable formulation is prescribed in severe hospital bacterial infections.
Cefoperazone & Tazobactam Injection delivers enhanced antibacterial coverage in severe infections.